Vietnam Pharmaceutical Logistics Market Size, Share, Trends and Forecast by Type, Component, Application, and Region, 2025-2033

Vietnam Pharmaceutical Logistics Market Overview:

The Vietnam pharmaceutical logistics market size reached USD 365.60 Million in 2024. The market is projected to reach USD 613.49 Million by 2033, exhibiting a growth rate (CAGR) of 5.92% during 2025-2033. The market is driven by the expansion of cold chain infrastructure to support temperature-sensitive drugs and biologics, regulatory modernization through the amended Law on Pharmacy enhancing foreign investment and distribution rights, and digital transformation with IoT-enabled monitoring systems ensuring GDP compliance and supply chain visibility. Additionally, the establishment of Vietnam's first pharmaceutical-biotechnology industrial park and increasing urbanization, driving demand for efficient logistics solutions, are expanding the Vietnam pharmaceutical logistics market share.

Vietnam Pharmaceutical Logistics Market Trends:

Expansion of Cold Chain Infrastructure

Vietnam's cold chain logistics sector is experiencing robust expansion as pharmaceutical companies and healthcare providers demand temperature-controlled storage and transportation solutions to ensure the efficacy and safety of temperature-sensitive drugs. The pharmaceutical industry in Vietnam is experiencing significant growth, necessitating sophisticated cold chain logistics to maintain product integrity throughout the supply chain. The fast-paced urbanization process is intensifying the need for temperature-controlled logistics infrastructure, driving expansion across both metropolitan hubs and rural distribution points to support efficient supply chain operations and meet growing consumer requirements. Unlike conventional warehousing, pharmaceutical cold chain logistics requires highly regulated and tech-enabled environments, incorporating reefer containers, blast freezers, multi-temperature chambers, and real-time condition monitoring systems that comply with Good Distribution Practice standards. With Southeast Asia becoming a key pharmaceutical manufacturing and export hub, Vietnam's healthcare logistics segment is especially driving demand for GxP-compliant cold storage facilities. The growth of modern retail, quick commerce, and health-conscious consumption has increased the movement of chilled and frozen pharmaceutical goods across distribution networks. In November 2024, the People's Council of Thai Binh province approved the zoning plan for Vietnam's first pharmaceutical-biotechnology industrial park in Quynh Phu district. The 334-hectare facility will require infrastructure investment of approximately VND 3.8 trillion and is expected to attract investments worth USD 800 million from 2024 to 2027 and USD 1.2 billion from 2028 to 2030. The planned park is set to include research and development centers, a biotechnology zone, warehousing facilities, logistics hubs, and commercial spaces, with construction scheduled to commence in 2025. This strategic development demonstrates the government's commitment to building specialized pharmaceutical infrastructure that will support the Vietnam pharmaceutical logistics market growth in the coming years.

Regulatory Modernization Enhancing Foreign Investment and Distribution Rights

The Vietnamese government is implementing significant regulatory reforms to modernize the pharmaceutical sector and attract foreign investment. The National Assembly passed the Law on Amendments and Supplements to the Law on Pharmacy in November 2024, which introduces comprehensive changes aimed at streamlining administrative procedures, expanding market access for foreign-invested enterprises, and improving transparency in pharmaceutical distribution. These amendments directly address critical limitations in existing regulations by clarifying the rights of foreign pharmaceutical manufacturers to wholesale, transport, and distribute drugs they produce domestically, including products manufactured through technology transfer arrangements. Previously, foreign-invested pharmaceutical companies faced strict restrictions prohibiting them from engaging in pharmaceutical distribution and related activities such as preservation, transportation, and receipt of orders and payments, forcing them to sell products to domestic pharmaceutical distributors. The reformed legal framework now sets forth an exhaustive list of activities deemed relevant to pharmaceutical distribution, removing catch-all phrases that created operational uncertainty. The reforms also legalize e-commerce pharmaceutical sales for non-prescription drugs and simplify drug registration procedures, with reference-based approvals shortened to nine months compared to the previous twelve-month timeline. The amended Law on Pharmacy, set to take full effect on July 1, 2025, formally establishes the legal framework for pharmacy chains and expands the rights of foreign-invested pharmaceutical companies. Specifically, foreign pharmaceutical manufacturers are now permitted to wholesale and transport not only drugs and active pharmaceutical ingredients they produce domestically but also drugs produced through domestic manufacturing contracts or technology transfer arrangements, allowing greater control over supply chains and improved quality assurance throughout the distribution process. By taking direct control of transportation and storage, foreign-invested enterprises can mitigate risks associated with improper handling, ensuring the safety and efficacy of pharmaceutical products throughout the distribution process and reducing operational costs through more efficient supply chain management.

Digital Transformation and GDP Compliance

Vietnam's pharmaceutical logistics market is undergoing rapid digital transformation as companies adopt Internet of Things technology, real-time monitoring systems, and blockchain-enabled tracking to ensure compliance with Good Distribution Practice standards and maintain product integrity throughout the supply chain. Vietnam’s IoT market is witnessing rapid expansion, creating new opportunities for pharmaceutical logistics providers to enhance cold chain management. Real-time monitoring and optimization enabled by IoT technologies help ensure regulatory compliance, maintain product safety, and minimize waste. Improved traceability and data-driven insights further strengthen operational efficiency while reinforcing confidence in the quality and reliability of temperature-sensitive goods. Pharmaceutical companies and global food distributors are demanding end-to-end visibility, pushing logistics providers to adopt IoT temperature sensors, data loggers, and predictive maintenance tools for refrigeration units to maintain the stringent temperature control required for biologics, vaccines, and gene therapies. The market is seeing growth in modular cold storage solutions, such as plug-and-play cold rooms and portable reefer units, which are particularly valuable in Tier 2 and Tier 3 cities where permanent infrastructure is still developing. Digital control towers integrating GPS, IoT, and blockchain tools now orchestrate modal transfers, enhancing visibility and regulatory compliance across pharmaceutical logistics networks. To conduct business in Vietnam, local manufacturers are required to adhere to Good Manufacturing Practice (GMP) standards, while importers must follow Good Storage Practice (GSP) guidelines. Distributors are obligated to comply with both GSP and Good Distribution Practice (GDP) standards, and retailers must meet the criteria outlined in Good Pharmacy Practice (GPP) regulations, creating strong incentives for logistics providers to invest in technology-enabled compliance solutions. According to the World Bank, Vietnam’s urbanization is advancing rapidly, with the urban population expected to exceed half of the country’s total by late 2025. This growing concentration in cities is intensifying the need for reliable cold chain logistics to ensure the integrity of temperature-sensitive pharmaceuticals. Efficient storage and transportation systems are increasingly vital to preserve product quality across complex distribution networks linking production sites, warehouses, hospitals, pharmacies, and healthcare facilities nationwide.

Vietnam Pharmaceutical Logistics Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the country and regional levels for 2025-2033. Our report has categorized the market based on type, component, and application.

Type Insights:

• Non Cold Chain
• Cold Chain

The report has provided a detailed breakup and analysis of the market based on the type. This includes non cold chain and cold chain.

Component Insights:

• Storage
  • Warehouse
  • Refrigerated Container
• Transportation
  • Sea Freight Logistics
  • Airfreight Logistics
  • Overland Logistics
• Monitoring
  • Hardware
  • Software

A detailed breakup and analysis of the market based on the component have also been provided in the report. This includes storage (warehouse and refrigerated container), transportation (sea freight logistics, airfreight logistics, and overland logistics), and monitoring (hardware and software).

Application Insights:

• Bio Pharma
• Chemical Pharma
• Specialty Pharma

The report has provided a detailed breakup and analysis of the market based on the application. This includes bio pharma, chemical pharma, and specialty pharma.

Regional Insights:

• Northern Vietnam
• Central Vietnam
• Southern Vietnam

The report has also provided a comprehensive analysis of all the major regional markets, which include Northern Vietnam, Central Vietnam, and Southern Vietnam.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Vietnam Pharmaceutical Logistics Market News:

• April 2025: DHL Group has announced a strategic plan to invest EUR 2 billion over the next five years to strengthen its logistics infrastructure for the life sciences and healthcare sectors worldwide. The investment will be distributed across major regions, with half directed toward the Americas, and the remainder split equally between Asia Pacific and the EMEA region. Through this expansion, DHL aims to enhance its global network to provide faster, more integrated, and dependable logistics solutions. The initiative is designed to meet the rising demand across the pharmaceutical, medical device, and emerging segments such as clinical trials, biopharma, and cell and gene therapies. It also includes significant upgrades in temperature-controlled transportation and storage technologies to support advanced therapeutic solutions.
• March 2025: DHL Group acquired CRYOPDP from Cryoport to strengthen its specialized pharmaceutical logistics capabilities. CRYOPDP is a leading provider of premium courier solutions for the life sciences and healthcare industries, operating across 15 countries and managing hundreds of thousands of shipments annually to serve customers and patients in more than 135 global markets. The acquisition represents a major milestone in DHL’s strategy to strengthen its expertise in specialized pharmaceutical logistics and broaden its portfolio within the rapidly expanding life sciences and healthcare sector.
• March 2025: Singapore Prime Minister Lawrence Wong and Vietnam Prime Minister Pham Minh Chinh witnessed the virtual groundbreaking of the Vietnam-Singapore Industrial Park in Thai Binh province. The 333-hectare facility is part of Vietnam's North Central region, close to the northern key economic zone. Upon completion of the highway linking Thai Binh province with Lach Huyen Port, the industrial park will be well-positioned to serve as a satellite facility supporting existing large manufacturers, while attracting investments in high-tech and large-scale manufacturing industries, including pharmaceuticals that require robust logistics infrastructure.

Vietnam Pharmaceutical Logistics Market Report Coverage:

Key Questions Answered in This Report:

• How has the Vietnam pharmaceutical logistics market performed so far and how will it perform in the coming years?
• What is the breakup of the Vietnam pharmaceutical logistics market on the basis of type?
• What is the breakup of the Vietnam pharmaceutical logistics market on the basis of component?
• What is the breakup of the Vietnam pharmaceutical logistics market on the basis of application?
• What is the breakup of the Vietnam pharmaceutical logistics market on the basis of region?
• What are the various stages in the value chain of the Vietnam pharmaceutical logistics market?
• What are the key driving factors and challenges in the Vietnam pharmaceutical logistics market?
• What is the structure of the Vietnam pharmaceutical logistics market and who are the key players?
• What is the degree of competition in the Vietnam pharmaceutical logistics market?

Key Benefits for Stakeholders:

• IMARC's industry report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the Vietnam pharmaceutical logistics market from 2019-2033.
• The research report provides the latest information on the market drivers, challenges, and opportunities in the Vietnam pharmaceutical logistics market.
• Porter's five forces analysis assist stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the Vietnam pharmaceutical logistics industry and its attractiveness.
• Competitive landscape allows stakeholders to understand their competitive environment and provides an insight into the current positions of key players in the market.